Overview

Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain

Status:
Recruiting

Trial end date:
2025-06-30

Target enrollment:

Participant gender:

Summary

This study will use a randomized controlled design to test whether medical marijuana use by adults on high-dose chronic opioid therapy (COT) for chronic non-cancer pain (CNCP) is associated with reduced opioid dose and improved pain severity when added to a 24-week behavioral intervention (POTS).

Phase:

N/A

Details

Lead Sponsor:

Massachusetts General Hospital

Treatments:

Analgesics, Opioid